OMNI BIO PHARMACEUTICAL, INC.·4

Jan 3, 6:22 PM ET

Schneider Bruce E. 4

4 · OMNI BIO PHARMACEUTICAL, INC. · Filed Jan 3, 2013

Insider Transaction Report

Form 4
Period: 2013-01-01
Schneider Bruce E.
DirectorChief Executive Officer
Transactions
  • Award

    Warrants (Right to Buy)

    2013-01-01+1,500,0001,500,000 total
    Exercise: $0.30Exp: 2020-01-01Common Stock (1,500,000 underlying)
  • Award

    Warrants (Right to Buy)

    2013-01-01+1,500,0001,500,000 total
    Exp: 2020-01-01Common Stock (1,500,000 underlying)
Footnotes (3)
  • [F1]Fifty percent (50%) of the warrants vested and became exercisable on January 1, 2013. The remaining warrants vest and become exercisable on June 30, 2013, provided that the reporting person remains employed with the issuer on the vesting date.
  • [F2]The exercise price is the equal to the lower of $1.00 per share or the market price of the issuer's common stock on each date that certain milestones are achieved.
  • [F3]The warrants vest and become exercisable upon the achievement of certain milestones by the issuer.

Documents

1 file
  • 4
    rrd365567.xmlPrimary